Helius Medical (HSDT) Technologies announced that on June 3, 2025, Helius received formal notice from the Nasdaq Hearings Panel of The Nasdaq Stock Market indicating that Helius has evidenced full compliance with the minimum bid price requirement set forth Listing Rules 5550(a)(2).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSDT:
- Helius Medical files to sell 3.45M shares of common stock
- Helius Medical Approves Reverse Stock Split and Share Increase
- Helius Medical highlights results of new study on PoNS
- Helius Medical announces reimbursement by healthcare provider for PoNS device
- HSDT Earnings Report this Week: Is It a Buy, Ahead of Earnings?